Thyroid hormone metabolism and thyroid diseases in chronic renal failure

Endocrine Reviews

Volumn 17, Issue 1, 1996, Pages 45-63

  Kaptein, Elaine May ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,3',5' TRIIODOTHYRONINE; AZATHIOPRINE; ERYTHROPOIETIN; IODIDE; LIOTHYRONINE; NITROGEN; PREDNISONE; THYROID HORMONE; THYROTROPIN; THYROXINE; ZINC;

ANEMIA; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; DIALYSIS; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; GOITER; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; KIDNEY TRANSPLANTATION; NITROGEN BALANCE; PRIORITY JOURNAL; REVIEW; THYROID CARCINOMA; THYROID DISEASE; THYROID HORMONE METABOLISM; THYROID NODULE; ZINC DEFICIENCY;

EID: 0030051476     PISSN: 0163769X     EISSN: None     Source Type: Journal    
DOI: 10.1210/edrv-17-1-45     Document Type: Review

References (128)

1. US Renal Data System USRDS 1994 Annual Data Report, The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD. Am J Kidney Dis 24[Suppl 2]:S12-S94
2. Excerpts from the United States Renal Data System 1993 Annual Data Report, The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD. Am J Kidney Dis 22[Suppl 2]:17-68
3. Kaptein EM, Quion-Verde H, Chooljian CJ, Tang WW, Friedman PE, Rodriquez HJ, Massry SG 1988 The thyroid in end-stage renal disease. Medicine (Baltimore) 67:187-197
4. Blake PG, Flowerdew G, Blake RM, Oreopoulos DG 1993 Serum albumin in patients on continuous ambulatory peritoneal dialysis - predictors and correlations with outcomes. J Am Soc Nephrol 3:1501-1507
5. Owens WF, Lew NL, Liu Y, Lowrie EG, Lazarus JM 1993 The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med 329: 1001-1006
6. Hull AR 1994 Dialysis-related mortality in the United States. Cleve Clin J Med 61:393-397
7. Hardy MJ, Ragbeer SS, Nascimento L 1988 Pituitary-thyroid function in chronic renal failure assessed by a highly sensitive thyrotropin assay. J Clin Endocrinol Metab 66:233-236
8. Brent GA, Hershman JM 1986 Thyroxine therapy in patients with severe nonthyroidal illnesses and low serum thyroxine concentration. J Clin Endocrinol Metab 63:1-8
9. Hamblin PS, Dyer SA, Mohr VS, Le Grand BA, Lim C-F, Tuxen DV, Topliss DJ, Stockigt JR 1986 Relationship between thyrotropin and thyroxine changes during recovery from severe hypothyroxinemia of critical illness. J Clin Endocrinol Metab 62:717-722
10. Spencer CA, Eigen A, Shen D, Duda M, Qualls S, Weiss S, Nicoloff JT 1991 Specificity of sensitive assays of thyrotropin (TSH) used to screen for thyroid disease in hospitalized patients. Clin Chem 33:1391-1396
11. Kaptein EM 1991 The effects of systemic illness on thyroid hormone metabolism. In: Wu S-Y (ed) Current Issues in Endocrinology and Metabolism: Thyroid Hormone Metabolism - Regulation and Clinical Implications. Blackwell Scientific Publications, Boston, pp 211-237
12. Horimoto M, Nishikawa M, Ishihara T, Yoshikawa N, Yoshimura M, Inada M 1995 Bioactivity of thyrotropin (TSH) in patients with central hypothyroidism: comparison between in vivo 3,5,3′-triiodothyronine response to TSH and in vitro bioactivity of TSH. J Clin Endocrinol Metab 80:1124-1128
13. Kaptein EM, Spencer CA, Kamiel MB, Nicoloff JT 1980 Prolonged dopamine administration and thyroid hormone economy in normal and critically ill subjects. J Clin Endocrinol Metab 51:387-393
14. Wilber JF, Utiger RD 1969 The effect of glucocorticoids on thyrotropin secretion. J Clin Invest 48:2096-2103
15. Brabant G, Brabant A, Ranft U, Ocran K, Kohrle J, Hesch RD, von zur Muhlen A 1987 Circadian and pulsatile thyrotropin secretion in euthyroid man under the influence of thyroid hormone and glucocorticoid administration. J Clin Endocrinol Metab 65:83-88
16. Spencer CA, LoPresti JS, Patel A, Guttler RB, Eigen A, Shen D, Gray D, Nicoloff JT 1990 Applications of a new chemiluminometric thyrotropin assay to subnormal measurement. J Clin Endocrinol Metab 70:453-460
17. Docter R, Krenning EP, de Jong M, Hennemann G 1993 The sick euthyroid syndrome: changes in thyroid hormone serum parameters and hormone metabolism. Clin Endocrinol (Oxf) 39:499-518
18. Ramirez G, O'Neill W, Jubiz W, Bloomer HA 1976 Thyroid dysfunction in uremia: evidence for thyroid and hypophyseal abnormalities. Ann Intern Med 84:672-676
19. Lim SL, Fang VS, Katz AI, Refetoff S 1977 Thyroid dysfunction in chronic renal failure: a study of the pituitary-thyroid axis and peripheral turnover kinetics of thyroxine and triiodothyronine. J Clin Invest 60:522-534
20. Wartofsky L, Burman KD 1982 Alterations in thyroid function in patients with systemic illnesses: the "euthyroid sick syndrome". Endocr Rev 3:164-217
21. Duntas L, Wolf CF, Keck FS, Rosenthal J 1992 Thyrotropin-releasing hormone: pharmacokinetic and pharmacodynamic properties in chronic renal failure. Clin Nephrol 38:214-218
22. Ramirez G, Bittle PA, Sanders H, Bereu BB 1992 Hypothalamo-hypophyseal thyroid and gonadal function before and after erythropoietin therapy in dialysis patients. J Clin Endocrinol Metab 74:517-524
23. Kaptein EM 1986 Thyroid hormone metabolism in illness. In: Hennemann G (ed) Thyroid Hormone Metabolism, Basic and Clinical Endocrinology Series. Marcel-Dekker, New York, vol 8:297-333
24. Wheatley T, Clark PMS, Clark JDA, Holder R, Raggatt PR, Evans DB 1989 Abnormalities of thyrotrophin (TSH) evening rise and pulsatile release in haemodialysis patients: evidence for hypothalamic-pituitary changes in chronic renal failure. Clin Endocrinol (Oxf) 31:39-50
25. Bartalena L, Pacchiarotti A, Palla R, Antonangeli L, Mammoli C, Monzani F, De Negri F, Panichi V, Martino E, Baschieri L, Pinchera A 1990 Lack of nocturnal serum thyrotropin (TSH) surge in patients with chronic renal failure undergoing regular maintenance hemofiltration: a case of central hypothyroidism. Clin Nephrol 34:30-34
26. Beckers C, Machiels J, Soyez C, Cornette C 1971 Metabolic clearance rate and production rate of thyroid stimulating hormone in man. Horm Metab Res 3:34-40
27. Constant RB, Weintraub BD 1986 Differences in the metabolic clearance of pituitary and serum thyrotropin (TSH) derived from euthyroid and hypothyroid rats: effects of chemical deglycosylation of pituitary TSH. Endocrinology 119:2720-2727
28. Lee H-Y, Suhl J, Pekary E, Hershman JM 1987 Secretion of thyrotropin with reduced concavalin-A-binding activity in patients with severe nonthyroidal illness. J Clin Endocrinol Metab 65:942-945
29. Papandreou M-J, Persani L, Asteria C, Ronin C, Beck-Peccoz P 1993 Variable carbohydrate structures of circulating thyrotropin as studied by lectin affinity chromatography in different clinical conditions. J Clin Endocrinol Metab 77:393-398
30. Medri G, Carella C, Padmanabhan V, Rossi CM, Amato G, De Santo NG, Beitins IZ, Beck-Peccoz P 1993 Pituitary glycoprotein hormones in chronic renal failure: evidence for an uncontrolled alpha-subunit release. J Endocrinol Invest 16:169-174
31. Horimoto M, Nishikawa M, Yoshikawa N, Inada M 1989 A sensitive and practical bioassay for thyrotropin using cultured FRTL-5 cells: assessment of bioactivity for serum TSH in patients with chronic renal failure. Acta Endocrinol (Copenh) 121:191-196
32. Kaptein EM, Feinstein EI, Nicoloff JT, Massry SG 1983 Serum reverse triiodothyronine and thyroxine kinetics in patients with chronic renal failure. J Clin Endocrinol Metab 57:181-189
33. Hershman JM, Krugman LG, Kopple JD, Reed AW, Azukizawa M, Shinaberger JH 1978 Thyroid function in patients undergoing maintenance hemodialysis: unexplained low serum thyroxine concentration. Metabolism 27:755-759
34. Faber J, Heaf J, Kirkegaard C, Lumholtz IB, Siersbaek-Nielsen K, Kolendorf K, Friis T 1983 Simultaneous turnover studies of thyroxine, 3,5,3′- and 3,3′,5′-triiodothyronine, 3,5-, 3,3′- and 3′,5′-diiodothyronine, and 3′-monoiodothyronine in chronic renal failure. J Clin Endocrinol Metab 56:211-217
35. Neuhaus K, Baumann G, Walser A, Thoen H 1975 Serum thyroxine, thyroxine-binding proteins in chronic renal failure without nephrosis. J Clin Endocrinol Metab 41:395-398
36. Wassner SJ, Buckingham BA, Kershnar AJ, Malekzadeh MH, Pennisi AJ, Fine RN 1977 Thyroid function in children with chronic renal failure. Nephron 19:236-241
37. 3 assay for predicting glucose intolerance in uremic patients on dialysis therapy. Clin Nephrol 27:189-198
38. Arreola F, Paniagua R, Perez A, Diaz-Bensussen S, Junco E, Villalpando S, Exaire E 1993 Effect of zinc treatment on serum thyroid hormones in uremic patients under peritoneal dialysis. Horm Metab Res 25:539-542
39. Sakurai S, Kara Y, Miura S, Urabe M, Inoue K, Tanikawa T, Yanagisawa M, IItaka M, Ishii J 1988 Thyroid function before and after maintenance hemodialysis in patients with chronic renal failure. Endocrinol Jpn 35:865-876
40. Lim C-F, Bernard BF, de Jong M, Docter R, Krenning EP, Hennemann G 1993 A furan fatty acid and indoxyl sulfate are the putative inhibitors of thyroxine hepatocyte transport in uremia. J Clin Endocrinol Metab 76:318-324
41. Pereira BJG, Shapiro L, King AJ, Falagas ME, Strom JA, Dinarella CA 1994 Plasma levels of IL-1B, TNFα and their specific inhibitors in undialyzed chronic renal failure, CAPD and hemodialysis patients. Kidney Int 45:890-896
42. Lim C-F, Curtis AJ, Barlow JW, Topliss DJ, Stockigt JR 1991 Interactions between oleic acid and drug competitors influence specific binding of thyroxine in serum. J Clin Endocrinol Metab 73:1106-1110
43. Boelen A, Schiphorst P-T MC, Wiersinga WM 1993 Association between serum interleukin-6 and serum 3,5,3′-triiodothyronine in nonthyroidal illness. J Clin Endocrinol Metab 77:1695-1699
44. Chopra IJ, Sakane S, Teco GNC 1991 A study of the serum concentration of tumor necrosis factor-a in thyroidal and nonthyroidal illnesses. J Clin Endocrinol Metab 72:1113-1116
45. Lim C-F, Docter R, Visser TJ, Krenning EP, Bernard B, van Toor H, de Jong M, Hennemann G 1993 Inhibition of thyroxine transport into cultured rat hepatocytes by serum of nonuremic critically ill patients: effects of bilirubin and nonesterified fatty acids. J Clin Endocrinol Metab 76:1165-1172
46. Munro SL, Lim C-F, Hall JG, Barlow JW, Craik DJ, Topliss DJ, Stockigt JR 1989 Drug competition for thyroxine binding to transthyretin (prealbumin): comparison with effects on thyroxine-binding globulin. J Clin Endocrinol Metab 68:1141-1147
47. Oppenheimer JH, Schwartz HL, Mariash CN, Kaiser FE 1982 Evidence for a factor in the sera of patients with nonthyroidal disease which inhibits iodothyronine binding by solid matrices, serum proteins, and rat hepatocytes. J Clin Endocrinol Metab 54: 757-766
48. Woeber KA, Maddux BA 1981 Thyroid hormone binding in non-thyroidal illness. Metabolism 30:412-416
49. Lim C-F, Docter R, Visser TJ, Krenning EP, Bernard B, van Toor H, de Jong M, Hennemann G 1993 Inhibition of thyroxine transport into cultured rat hepatocytes by serum of nonuremic critically ill patients: effects of bilirubin and nonesterified fatty acids. J Clin Endocrinol Metab 76:1165-1172
50. Sarne DH, Refetoff S 1985 Measurement of thyroxine uptake from serum by cultured human hepatocytes as an index of thyroid status: reduced thyroxine uptake from serum of patients with nonthyroidal illness. J Clin Endocrinol Metab 61:1046-1052
51. Kaptein EM 1993 Clinical application of free thyroxine determinations. Clin Lab Med 13:653-672
52. 4 immunoassays. J Clin Endocrinol Metab 79:76-79
53. Kaptein EM 1994 Thyroid in vitro testing in non-thyroid illness. Exp Clin Endocrinol 102:92-101
54. Nelson JC, Wilcox RB, Pandian MR 1992 Dependence of free thyroxine estimates obtained with equilibrium tracer dialysis on the concentration of thyroxine-binding globulin. Clin Chem 38: 1294-1300
55. 4 concentrations in simple solutions. J Clin Endocrinol Metab 79:1373-1375
56. Spector DA, Davis PJ, Helderman JH, Bell B, Utiger RD 1976 Thyroid function and metabolic state in chronic renal failure. Ann Intern Med 85:724-730
57. Melmed S, Geola FL, Reed AW, Pekary AE, Park J, Hershman JM 1982 A comparison of methods for assessing thyroid function in nonthyroidal illness. J Clin Endocrinol Metab 54:300-306
58. 4 syndrome' in subjects on regular hemodialysis and continuous ambulatory peritoneal dialysis. Nephron 46:225-230
59. 3) in systemic illnesses. J Clin Endocrinol Metab 41:1043-1049
60. Mooradian AD, Reed RL, Osterweil D, Schiffman R, Scuderi P 1990 Decreased serum triiodothyronine is associated with increased concentrations of tumor necrosis factor. J Clin Endocrinol Metab 71:1239-1242
61. van der Poll T, Romijn JA, Wiersinga WM, Sauerwein HP 1990 Tumor necrosis factor: a putative mediator of the sick euthyroid syndrome in man. J Clin Endocrinol Metab 71:1567-1572
62. Williams GR, Franklyn JA, Neuberger JM, Sheppard MC 1989 Thyroid hormone receptor expression in the "sick euthyroid" syndrome. Lancet 2:1477-1481
63. Lim VS, Passo C, Murata Y, Ferrari E, Nakamura H, Refetoff S 1984 Reduced triiodothyronine content in liver but not pituitary of the uremic rat model: demonstration of changes compatible with thyroid hormone deficiency in liver only. Endocrinology 114:280-286
64. Smallridge RC, Wartofsky L, Desjarding RE, Burman KD 1978 Metabolic clearance and production rates of 3,3′,5′-triiodothyronine in hyperthyroid, euthyroid, and hypothyroid subjects. J Clin Endocrinol Metab 47:345-349
65. Savdie E, Stewart JH, Mahony JF, Hayes JM, Lazarus L, Simons LA 1978 Circulating thyroid hormone levels and adequacy of dialysis. Clin Nephrol 9:68-72
66. Robey C, Shreedhar K, Batuman V 1989 Effects of chronic peritoneal dialysis on thyroid function tests. Am J Kidney Dis 12:99-103
67. Ross RJM, Goodwin FJ, Houghton BJ, Boucher BJ 1985 Alteration of pituitary-thyroid function in patients with chronic renal failure treated by haernodialysis or continuous ambulatory peritoneal dialysis. Ann Clin Biochem 22:156-160
68. Lim VS, Flanigan MJ, Zavala DC, Freeman RM 1985 Protective adaptation of low serum triiodothyronine in patients with chronic renal failure. Kidney Int 28:541-549
69. 3 or "sick euthyroid syndrome": update 1994. In: Braverman LE, Refetoff S (eds) Clinical and Molecular Aspects of Diseases of the Thyroid. Endocr Rev Monographs 3:248-251
70. Koutsikos D, Sarandakou A, Agroyannis B, Tzanatos H, Tsoutsos D, Konstadinidou I, Phocas I 1990 The effect of successful renal transplantation on hormonal status of female recipients. Ren Fail 12:125-132
71. Bratusch-Marrain P, Kopsa H, Pils P, Waldhausl W, Zazgornic J, Schmidt P 1980 Persistent pituitary-thyroid dysfunction in patients following renal transplantation. Clin Nephrol 14:66-70
72. Samojlik E, Kirschner MA, Ribot S, Szmal E 1992 Changes in the hypothalamic-pituitary-gonadal axis in men after cadaver kidney transplantation and cyclosporine therapy. J Androl 13:332-336
73. Nicoloff JT, Fisher DA, Appleman MD 1970 The role of glucocorticoids in the regulation of thyroid function in man. J Clin Invest 49:1922-1929
74. 3). J Clin Endocrinol Metab 41:911-920
75. 4. J Clin Endocrinol Metab 42:976-978
76. Brabant G, Brabant A, Ranft U, Ocran K, Kohrle J, Hesch RD, von zur Muhlen A 1987 Circadian and pulsatile thyrotropin secretion in euthyroid man under the influence of thyroid hormone and glucocorticoid administration. J Clin Endocrinol Metab 65:83-88
77. Kaptein EM, Moore GE, Ferguson DC, Hoenig M 1992 Effects of prednisone on thyroxine and 3,5,3′-triiodothyronine metabolism in normal dogs. Endocrinology 130:1669-1679
78. Gamstedt A, Jarnerot G, Kagedal B 1981 Dose related effects of betamethasone on iodothyronines and thyroid hormone-binding proteins in serum. Acta Endocrinol (Copenh) 96:484-490
79. Beckers C, van Ypersele de Strihou C, Coche E, Troch R, Malvaux P 1969 Iodine metabolism in severe renal insufficiency. J Clin Endocrinol Metab 29:293-296
80. Koutras DA, Marketos SG, Rigopoulos GA, Malamos B 1972 Iodine metabolism in chronic renal insufficiency. Nephron 9:55-65
81. 131I. Proceedings of the National Kidney Foundation, Washington DC, 1990, p A7 (Abstract)
82. Becker DV, Danzig LE 1954 Kinetics of radioiodide distribution in chronic renal disease studied by means of the artificial kidney. In: Transactions of the American Goiter Association. Charles C Thomas, Chicago, pp 301-312
83. Sato K, Okamura K, Yoshinari M, Kuroda T, Ikenoue H, Okazawa K, Mizokami T, Onayama K, Fujishima M 1992 Reversible primary hypothyroidism and elevated serum iodine level in patients with renal dysfunction. Acta Endocrinol (Copenh) 126:253-259
84. Gardner DF, Mars DR, Thomas RG, Bumrungsup C, Misbin RI 1986 Iodine retention and thyroid dysfunction in patients on hemodialysis and continuous ambulatory peritoneal dialysis. Am J Kidney Dis 7:471-476
85. Mizukami Y, Michigishi T, Nonomura A, Hashimoto T, Tonami N, Matsubara F, Takazukura E 1993 Iodine-induced hypothyroidism: a clinical and histological study of 28 patients. J Clin Endocrinol Metab 76:466-471
86. Namba H, Yamashita S, Kimura H, Yokoyama N, Usa T, Otsuru A, Izumi M, Nagataki S 1993 Evidence of thyroid volume increase in normal subjects receiving excess iodide. J Clin Endocrinol Metab 76:605-608
87. Konno N, Makita H, Yuri K, Iizuka N, Kawasaki K 1994 Association between dietary iodine intake and prevalence of subclinical hypothyroidism in the coastal regions of Japan. J Clin Endocrinol Metab 78:393-397
88. 131I Treatment of thyroid papillary carcinoma in a patient with renal failure. Cancer 66:2509-2513
89. Kaptein EM, Levenson H, Siegel ME, Akmal M 1992 End-stage renal disease patients (ESRD) receiving chronic ambulatory peritoneal dialysis (CAPD) require reduced radioiodide dosage for thyroid cancer. Thyroid 2:S-16 (Abstract)
90. 132I as sodium iodide. J Nucl Med 16:857-860
91. Howard N, Glasser M 1981 Iodine 131 ablation therapy for a patient on maintenance haemodialysis. Br J Radiol 54:259
92. Oddie TH, Flanigan WJ, Fisher DA 1970 Iodine and thyroxine metabolism in anephric patients receiving chronic peritoneal dialysis. J Clin Endocrinol 31:277-282
93. Ronco C, Bosch JP, Lew SQ, Feriani M, Chiaramonte S, Conz P, Brendolan A, La Greca G 1994 Adequacy of continuous ambulatory peritoneal dialysis: comparison with other dialysis techniques. Kidney Int 46:[Suppl 48]S18-S24
94. Miki H, Oshimo K, Inoue H, Kawano M, Morimoto T, Monden Y, Yamamoto Y, Seizo K 1992 Thyroid carcinoma in patients with secondary hyperparathyroidism. J Surg Oncol 49:168-171
95. Miki H, Oshimo K, Inque H, Kawano M, Tanaka K, Komaki K, Uyama T, Kawauchi M, Minakuchi J, Kawashima S, Monden Y 1993 Thyroid nodules in female uremic patients on maintenance hemodialysis. J Surg Oncol 54:216-218
96. Prinz RA, Barbato AL, Braithwaite SS, Brooks MH, Emanuele MA, Gordone DL, Lawrence AM, Paloyan E 1982 Simultaneous primary hyperparathyroidism and nodular thyroid disease. Surgery 92:454-458
97. Kantor AF, Hoover RN, Kinlen LJ, McMullan R, Fraumeni JF 1987 Cancer in patients receiving long-term dialysis treatment. Am J Epidemiol 126:370-376
98. Penn I 1993 The effect of immunosuppression on pre-existing cancers. Transplantation 55:742-747
99. Schneider AB 1991 Carcinoma of follicular epithelium. In: Braverman LE, Utiger RD (eds) Werner and Ingbar's The Thyroid: A Fundamental and Clinical Text, ed 6. JB Lippincott Co, Philadelphia, pp 1121-1129
100. Brunner FP, Landais P, Selwood NH 1995 Malignancies after renal transplantation: the EDTA-ERA registry experience. Nephrol Dial Transplant 10[Suppl 1]:74-80
101. O'Leary DP, White HJO 1995 Parathyroidectomy for hyperparathyroidism associated with renal disease. Ann R Coll Surg Engl 77:97-101
102. Penn I 1994 Malignancy. Surg Clin N Am 74:1247-1257
103. Divakar D, Bailey RR, Lynn KL, Robson RA 1991 Long-term complications following renal transplantation. N Z Med J 104:352-354
104. Barrett WL, First MR, Aron BS, Penn I 1993 Clinical course of malignancies in renal transplant recipients. Cancer 72:2186-2189
105. Ochiai T, Asano T, Isono K 1987 Development of malignancies in Japanese renal transplant recipients. Transplant Proc 19:2967-2970
106. Dulgeroff AJ, Hershman JM 1994 Medical therapy for differentiated thyroid carcinoma. Endocr Rev 15:500-515
107. 131I thyroxine and thyroid cancer. Thyroid 4:195-198
108. Robuschi G, Safran M, Braverman L, Gnudi A, Roti E 1987 Hypothyroidism in the elderly. Endocr Rev 8:142-153
109. Takeda S-I, Michigishi T, Takazukura E 1993 Iodine-induced hypothyroidism in patients on regular dialysis treatment. Nephron 65:51-55
110. Gavin LA, Eitan NF, Cavalieri RR, Schmidt WR 1983 Hypothyroidism induced by continuous ambulatory peritoneal dialysis. West J Med 138:562-565
111. Enia G, Costante G, Catalano C, Zoccali C, Maggiore Q 1987 Severe hypothyroidism induced by amiodarone in a dialysis patient. Nephron 46:206-207
112. Tang WW, Kaptein EM, Massry SG 1987 Diagnosis of hypothyroidism in patients with end-stage renal disease. Am J Nephrol 7:192-197
113. Mandel SJ, Brent GA, Larsen PR 1993 Levothyroxine therapy in patients with thyroid disease. Ann Intern Med 119:492-502
114. Roti E, Minelli R, Gardini E, Braverman LE 1993 The use and misuse of thyroid hormone. Endocr Rev 14:401-423
115. Toft AD 1994 Thyroxine therapy. N Engl J Med 331:174-180
116. McLean M, Kirkwood I, Epstein M, Jones B, Hall C 1993 Cation-exchange resin and inhibition of intestinal absorption of thyroxine (letter). Lancet 341:1286
117. Sperber AD, Liel Y 1992 Evidence for interference with intestinal absorption of levothyroxine sodium by aluminum hydroxide. Arch Intern Med 152:183-184
118. Soffer O, Chary KR, Dallas W 1980 Clinical hyperthyroidism in a patient receiving long-term hemodialysis. Arch Intern Med 140: 708-709
119. Foley RJ, Hamner RW 1985 Hyperthyroidism in end-stage renal disease. Am J Nephrol 5:292-295
120. McKillop JH, Leung ACT, Wilson R 1985 Successful management of Graves' disease in a patient undergoing regular dialysis therapy. Arch Intern Med 145:337-339
121. Cooper DS, Steigerwalt S, Migdal S 1987 Pharmacology of propylthiouracil in thyrotoxicosis and chronic renal failure. Arch Intern Med 147:785-786
122. Alarcon RD, Groover AM, Jenkins-Ross CS 1992 Organic anxiety disorder secondary to hyperthyroidism in a hemodialysis patient: a rare occurrence. Psychosomatics 33:457-460
123. Absy M, Ng YC 1993 Recurrence of thyrotoxicosis after correction of uraemia in a patient with chronic renal failure (letter). Nephron 65:326
124. Nibhanupudy JR, Hamilton W, Sridhar R, Tallery GB, Chughtai GM, Ashayeri E, Goldson AL 1993 Iodine-131 treatment of hyperthyroidism in a patient on dialysis for chronic renal failure. Am J Nephrol 13:214-217
125. Davis PJ, Davis FB 1974 Hyperthyroidism in patients over the age of 60 years - clinical features in 85 patients. Medicine (Baltimore) 53:161-181
126. Franklyn JA 1994 The management of hyperthyroidism. N Engl J Med 330:1731-1738
127. Klein I, Becker DV, Levey GS 1994 Treatment of hyperthyroid disease. Ann Intern Med 121:281-288
128. Kaptein EM, Hays MT, Ferguson DC 1994 Thyroid hormone metabolism: a comparative evaluation. In: Ferguson DC (ed) The Veterinary Clinics of North America: Small Animal Practice: Thyroid Disorders. WB Saunders, Philadelphia vol 24:431-466